SAN ANTONIO, Texas--(BUSINESS WIRE)--Hospitals worldwide report they are unable to combat the outbreak of the deadly Candida auris fungus with traditional disinfectants. Researchers from the Centers for Disease Control and Prevention (CDC) recently published a study showing that C.auris has been spreading at an “alarming rate” throughout health care facilities and termed it an “urgent threat.”
However, hospitals using Xenex Disinfection Services’ LightStrike UV room disinfection robot have reported success battling the fungus, which is contaminating medical facilities and killing patients.
There are thousands of Xenex LightStrike robots deployed at more than 1,000 hospitals on five continents and across the U.S. They include Minnesota’s Mayo Clinic, Houston’s MD Anderson Cancer Center, Phoenix’s HonorHealth system, and 130+ U.S. military and Veterans Affairs medical facilities from coast-to-coast.
According to a study conducted in South Africa by Netcare Hospitals, the Xenex LightStrike robot is 99.6% effective at deactivating the C.auris fungus following a 10-minute treatment cycle.
CEO: World’s Most Powerful UV Robot
Xenex CEO Morris Miller explains how the technology works, “The LightStrike robot has a xenon lamp, when it pulses, it puts out broad-spectrum, high-intensity ultraviolet light that penetrates the cell wall, deactivating the cell and preventing it from replicating.”
Theater of Disinfection
Miller emphasizes that there are numerous makers of UV devices claiming they are effective at destroying viruses, bacteria, funguses and other pathogens, but few can produce credible evidence sustaining such claims.
He calls these UV devices part of “the theater of disinfection.” Miller stresses the efficacy of the Xenex LightStrike robot is proven in more than 45 peer-reviewed research studies.
According to the CDC, Candida auris fungus can remain active on surfaces for up to 28 days.
A Yale University Medical School doctor reports that traditional chemical disinfectants are unable to deactivate the fungus.
The LightStrike robot’s intense UV rays are beamed on floors, walls, countertops and other high-touch surfaces within healthcare facilities.
Pathogens such as Clostridioides difficile (C.diff), methicillin-resistant Staphylococcus aureus (MRSA), Acinetobacter, and Candida auris that may be left behind on high touch surfaces can transmit from patient to patient or patient to healthcare worker.
Some deadly superbugs are showing resistance to cleaning chemicals, making the pathogens even more difficult to remove.
The LightStrike robot utilizes intense bursts of pulsed xenon ultraviolet (UV) light to quickly deactivate viruses, bacteria and spores on surfaces and is effective against multi-drug resistant organisms found in hospitals, including MRSA, C.diff, and SARS-CoV-2.
The LightStrike robot is proven to be 99.9% effective at deactivating SARS-CoV-2, the virus that causes COVID-19, according to research conducted at the Texas Biomedical Research Institute.
Additionally, the LightStrike robot has been proven effective against Ebola virus and anthrax and can easily be incorporated into a facility’s biodefense strategy.
Robots for Sale
Sales of the devices skyrocketed during the COVID-19 pandemic. As a result, Xenex increased its manufacturing capacity and has robot inventory available now to assist healthcare facilities.
Not only did medical facilities purchase the LightStrike robot, but it was also sold to hotels, stadiums, arenas, schools, correctional facilities, and government facilities. They include the Beverly Hills Hilton, the Carolina Panthers Bank of America Stadium and the San Antonio Spurs AT&T Center.